Search research articles
Contact Us
Filters
Showing results (421-430 of 669) with videos related to
Page
of 67
Sort By:
Molecular Cancer Therapeutics
|
January 17, 2014
Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study
Rishil J Kathawala, Kamlesh Sodani, Kang Chen, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Largazole Arrests Cell Cycle at G1 Phase and Triggers Proteasomal Degradation of E2F1 in Lung Cancer Cells
Li-Chuan Wu, Zhe-Sheng Wen, Ya-Tao Qiu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 14, 2025
Targeting TRAP1-dependent metabolic reprogramming to overcome doxorubicin resistance in quiescent breast cancer
Muhammad Zubair Saleem, Ruyi Huang, Yingying Huang, et al.
Biochemical Pharmacology
|
November 16, 2018
Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
Ning Ji, Yuqi Yang, Zi-Ning Lei, et al.
Cancer Science
|
June 2, 2020
Dual TTK/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells
Zhuo-Xun Wu, Yuqi Yang, Guangsuo Wang, et al.
Journal of Evidence-Based Medicine
|
August 13, 2021
ATP-binding cassette (ABC) transporters in cancer: A review of recent updates
Jing-Quan Wang, Zhuo-Xun Wu, Yuqi Yang, et al.
Frontiers in Pharmacology
|
March 4, 2021
OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance
Yuqi Yang, Zhuo-Xun Wu, Jing-Quan Wang, et al.
Frontiers in Immunology
|
October 15, 2024
The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis
Zi-Ning Lei, Qiu-Xu Teng, Jagadish Koya, et al.
Experimental Cell Research
|
January 24, 2020
Overexpression of ABCG2 confers resistance to pevonedistat, an NAE inhibitor
Liu-Ya Wei, Zhuo-Xun Wu, Yang Yang, et al.
Frontiers in Cell and Developmental Biology
|
April 8, 2021
Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model
Zi-Ning Lei, Qiu-Xu Teng, Pranav Gupta, et al.
Page
of 67
Search research articles
Search
Showing results (421-430 of 669) with videos related to
Sort By:
Page
of 67
Molecular Cancer Therapeutics
|
January 17, 2014
Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study
Rishil J Kathawala, Kamlesh Sodani, Kang Chen, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Largazole Arrests Cell Cycle at G1 Phase and Triggers Proteasomal Degradation of E2F1 in Lung Cancer Cells
Li-Chuan Wu, Zhe-Sheng Wen, Ya-Tao Qiu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
March 14, 2025
Targeting TRAP1-dependent metabolic reprogramming to overcome doxorubicin resistance in quiescent breast cancer
Muhammad Zubair Saleem, Ruyi Huang, Yingying Huang, et al.
Biochemical Pharmacology
|
November 16, 2018
Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
Ning Ji, Yuqi Yang, Zi-Ning Lei, et al.
Cancer Science
|
June 2, 2020
Dual TTK/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells
Zhuo-Xun Wu, Yuqi Yang, Guangsuo Wang, et al.
Journal of Evidence-Based Medicine
|
August 13, 2021
ATP-binding cassette (ABC) transporters in cancer: A review of recent updates
Jing-Quan Wang, Zhuo-Xun Wu, Yuqi Yang, et al.
Frontiers in Pharmacology
|
March 4, 2021
OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance
Yuqi Yang, Zhuo-Xun Wu, Jing-Quan Wang, et al.
Frontiers in Immunology
|
October 15, 2024
The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis
Zi-Ning Lei, Qiu-Xu Teng, Jagadish Koya, et al.
Experimental Cell Research
|
January 24, 2020
Overexpression of ABCG2 confers resistance to pevonedistat, an NAE inhibitor
Liu-Ya Wei, Zhuo-Xun Wu, Yang Yang, et al.
Frontiers in Cell and Developmental Biology
|
April 8, 2021
Cabozantinib Reverses Topotecan Resistance in Human Non-Small Cell Lung Cancer NCI-H460/TPT10 Cell Line and Tumor Xenograft Model
Zi-Ning Lei, Qiu-Xu Teng, Pranav Gupta, et al.
Page
of 67